GABAA receptor availability is not altered in adults with autism spectrum disorder or in mouse models
MetadataShow full item record
Copyright © 2018 The Authors, some rights reserved. Preliminary studies have suggested that -aminobutyric acid type A (GABAA) receptors, and potentially the GABAA 5 subtype, are deficient in autism spectrum disorder (ASD). However, prior studies have been confounded by the effects of medications, and these studies did not compare findings across different species. We measured both total GABAA and GABAA 5 receptor availability in two positron emission tomography imaging studies. We used the tracer [11C]flumazenil in 15 adults with ASD and in 15 control individuals without ASD and the tracer [11C]Ro15-4513 in 12 adults with ASD and in 16 control individuals without ASD. All participants were free of medications. We also performed autoradiography, using the same tracers, in three mouse models of ASD: the Cntnap2 knockout mouse, the Shank3 knockout mouse, and mice carrying a 16p11.2 deletion. We found no differences in GABAA receptor or GABAA 5 subunit availability in any brain region of adults with ASD compared to those without ASD. There were no differences in GABAA receptor or GABAA 5 subunit availability in any of the three mouse models. However, adults with ASD did display altered performance on a GABA-sensitive perceptual task. Our data suggest that GABAA receptor availability may be normal in adults with ASD, although GABA signaling may be functionally impaired.
Showing items related by title, author, creator and subject.
Deleo, Domenica (1994)Prior to the commencement of this study in 1990, a number of reports had appeared in the literature describing the importance of insulin action during lactation in mammals (see Chapter 1). These studies investigated the ...
Portales-Casamar, E.; Swanson, D.; Liu, L.; De Leeuw, C.; Banks, K.; Ho Sui, S.; Fulton, D.; Ali, J.; Amirabbasi, M.; Arenillas, D.; Babyak, N.; Black, S.; Bonaguro, R.; Brauer, E.; Candido, T.; Castellarin, M.; Chen, J.; Chen, Y.; Cheng, J.; Chopra, V.; Docking, T.; Dreolini, L.; D'Souza, C.; Flynn, E.; Glenn, R.; Hatakka, K.; Hearty, T.; Imanian, B.; Jiang, S.; Khorasan-zadeh, S.; Komljenovic, I.; Laprise, S.; Liao, N.; Lim, J.; Lithwick, S.; Liu, F.; Liu, J.; Lu, M.; McConechy, M.; McLeod, A.; Milisavljevic, M.; Mis, J.; O'Connor, K.; Palma, B.; Palmquist, D.; Schmouth, J.; Swanson, M.; Tam, B.; Ticoll, A.; Turner, J.; Varhol, Richard; Vermeulen, J.; Watkins, R.; Wilson, G.; Wong, B.; Wong, S.; Wong, T.; Yang, G.; Ypsilanti, A.; Jones, S.; Holt, R.; Goldowitz, D.; Wasserman, W.; Simpson, E. (2010)The Pleiades Promoter Project integrates genomewide bioinformatics with large-scale knockin mouse production and histological examination of expression patterns to develop MiniPromoters and related tools designed to study ...
Pigment epithelium-derived factor (PEDF) regulates metabolism and insulin secretion from a clonal rat pancreatic beta cell line BRIN-BD11 and mouse isletsChen, Y.; Carlessi, Rodrigo; Walz, N.; Cruzat, Vinicius; Keane, Kevin; John, A.; Jiang, F.; Carnagarin, R.; Dass, C.; Newsholme, Philip (2016)Pigment epithelium-derived factor (PEDF) is a multifunctional glycoprotein, associated with lipid catabolism and insulin resistance. In the present study, PEDF increased chronic and acute insulin secretion in a clonal rat ...